Dr. Reddy's Laboratories
190 hedge funds and large institutions have $1.07B invested in Dr. Reddy's Laboratories in 2023 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 69 increasing their positions, 44 reducing their positions, and 14 closing their positions.
214% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 14
57% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 44
33% more capital invested
Capital invested by funds: $805M → $1.07B (+$268M)
18% more funds holding
Funds holding: 161 → 190 (+29)
9.71% more ownership
Funds ownership: 46.7% → 56.41% (+9.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
66% less call options, than puts
Call options by funds: $154K | Put options by funds: $450K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$25.3M |
| 2 |
BlackRock
New York
|
+$25M |
| 3 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$20.4M |
| 4 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$9.28M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$5.12M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$3.02M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
-$2.43M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.14M |
| 5 |
Man Group
London,
United Kingdom
|
-$1.87M |
RDY Hedge Fund Activity: Q1 2023 in Review
190 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2023, worth a combined $1.07B — up 33% from $805M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new RDY positions and 14 closed out — a net gain of 30 holders — while 69 added to existing stakes and 44 trimmed.
The largest buyer was Bank of America, adding an estimated $25.3M. The largest seller was Connor, Clark & Lunn Investment Management (CC&L), cutting an estimated $5.12M.
- 190 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2023, up from 161 in Q4 2022.
- Funds reported $1.07B of Dr. Reddy's Laboratories stock for Q1 2023, up 33% quarter-over-quarter.
- 44 funds opened new Dr. Reddy's Laboratories positions in Q1 2023 and 14 closed out, a net change of +30 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2023 was Bank of America, an estimated $25.3M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2023 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $5.12M sold.
Based on aggregated 13F filings for Q1 2023.